Assessment of Treatment in the Clinic
All concerned with cancer of the breast are anxious for improvements in its treatment. In the absence of some dramatic and unforeseeable advance, the impact of which would be obvious, we must also be concerned with methods of demonstrating and measuring lesser steps that may be in the right direction.
KeywordsDoxorubicin Methotrexate Tamoxifen Estradiol Cyclophosphamide
Unable to display preview. Download preview PDF.
- 1.Collins, V.P., Loeffler, R.K. and Tivey, H. (1956) Observations on growth rates of human tumors. Am. J. Roentgenol. 76:988–1000.Google Scholar
- 2.Goldie, J.H., Coldman, A.J. and Gudauskas, G.A. (1982) Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat. Rep. 66:439–449.Google Scholar
- 5.Thomlinson, R.H., Johnson, A.E. and Cheung, C.W.D. (in preparation) Carcinoma of the breast: measurement and management of treatment. 1. The value of the data. 2. The regression of tumors.Google Scholar